For example, the UK SmPCs for liraglutide (Saxenda) and semaglutide (Wegovy/Ozempic), available via the Electronic Medicines Compendium (eMC), advise awareness of heart rate increases during treatment and recommend that clinicians consider discontinuation if a clinically relevant sustained rise in resting heart rate is observed
This mechanism operates similarly whether you weigh 220 pounds or 320 pounds, though individual response varies based on genetics, lifestyle, and metabolic factors
Above all, the experience continues to reward attention and restraint: stay observant, pace your choices, and you can convert small edges into sustainable outcomes across many sessions without letting variance dictate your entire narrative.
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a doubleblind, Phase IIIa, randomised trial published online 10/07/2024 Weiqing Wang, Stephen C